What an Adult Cardiologist Should Know about Cyanotic Congenital Heart Disease?
نویسندگان
چکیده
منابع مشابه
What an Adult Cardiologist Should Know about Cyanotic Congenital Heart Disease?
Congenital heart defects (CHDs) may be defined as malformations of the heart or great vessel occurring during intrauterine cardiac development, irrespective of the age at presentation. The incidence is approximately 1% of live births (8 per 1,000). The etiology is largely unknown and the majority can be explained by multifactorial inheritance hypothesis [1]. Advances in perinatal cardiac care, ...
متن کاملWhat Every Cardiologist Should Know about H1N1?
The world is witnessing ever fastest growing pandemic with high morbidity and mortality that excessive volume of airline travels spread influenza infection; so physicians with various specialties should know and consider the impact of current pandemic on their daily practice. Among influenza A viruses that infect humans, an influenza A virus emerged that had shifted to H1N1. Primarily, the resu...
متن کاملAdult cyanotic congenital heart disease.
The surgical treatment of cyanotic heart disease in the adult poses some technical difficulties in correcting severe anatomical deformities and compromised physiological states over a wide range of conditions. Various abnormalities and their surgical management have been reviewed. Forty-six patients over the age of 18 years have been operated with 10 operative deaths. Of the survivors, 63% have...
متن کاملWhat the cardiologist should know about trans fats.
Mailing address: Carlos Scherr • Avenida Visconde de Pirajá, 595/1204 22410-003 – Rio de Janeiro, RJ Brazil E-mail: [email protected] Manuscript received January 9, 2007; revised manuscript received April 4, 2007; accepted April 11, 2007. According to the World Health Organization1, 80% to 90% of people who die of coronary heart diseases have one or more risk factors directly associated with th...
متن کاملWhat every pediatrician should know about liver transplantation
Liver transplantation is the treatment of choice for children with end-stage liver disease. Improvement in outcomes (allograft and patient survival) has led to widespread use of pediatric LT worldwide. This success is due to improvement in patient selection, transplant surgery, anesthesia/postoperative care and immunosuppression management. This review will focus on different aspects of LT whi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiovascular Diseases & Diagnosis
سال: 2013
ISSN: 2329-9517
DOI: 10.4172/2329-9517.1000104